|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Protonix I.V.(pantoprazole sodium) Injection, Wyeth-Ayerst NDA 20-988/S7 2/21/03 3/10/03
Protonix I.V. (pantoprazole sodium) for Injection, equivalent to 40 mg, Wyeth-Ayerst NDA 20-988/S-003 Protonix I. V. (pantoprazole sodium) Injection, Wyeth-Ayerst NDA 20-988/S16 10/24/03
Protonix I. V. (pantoprazole sodium) Injection, Wyeth-Ayerst NDA 20-988/S3 10/18/01 11/6/01 11/6/01
Protonix I. V. (pantoprazole sodium) Injection, Wyeth-Ayerst NDA 20-988 3/22/01 4/4/02 4/4/02 4/4/02
Protonix Indication: Short-term treatment (7 to 10 days) of gastroesophageal reflux disease GERD).
Protonix (pantoprazole sodium) Delayed-Release Tablets & IV, Wyeth NDA 20-987/SLR-013 & 20-988/SLR-012 10/28/02 10/30/02 4/9/03
Protonix (pantoprazole sodium) Delayed-Release Tablets, 20 & 40 mg, Wyeth-Ayerst NDA 20-987/S7 4/19/02 5/2/02 4/22/02 7/31/02
Protonix (pantoprazole sodium) Delayed-Release Tablets, Wyeth-Ayerst NDA 20-987/S5 7/20/01 04/25/03
Protonix (pantoprazole sodium) Delayed-Release Tablets, 40 mg, Wyeth-Ayerst NDA 20-987S1 & S2 6/12/01 11/6/01
Protonix Indication: Maintenance of Healing of Erosive Esophagitis and control of daytime and nighttime heartburn symptoms in patients with gastroesophageal reflux disease (GERD).
Protonix (pantoprazole sodium) Delayed-Release Tablets Wyeth-Ayerst NDA 20-987 2/2/00 2/3/00 2/7/00 6/18/01
Protonix Indication: Short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease GERD). Protonix I. V. (pantoprazole sodium) Injection, Wyeth-Ayerst Protonix I.V.(pantoprazole sodium) Injection, Wyeth Protonix (pantoprazole sodium) Delayed-Release Tablets, Wyeth Pharmaceuticals, Inc. Protonix (pantoprazole) Delayed-Release Tablets, Wyeth Pharmaceuticals
Protonix I.V.(pantoprazole sodium) Injection, Wyeth Pharmaceuticals Protonix (pantoprazole) Delayed-Release Tablets, Wyeth Pharmaceuticals Protonix I. V. (pantoprazole sodium) Injection, Wyeth Pharmaceuticals Protonix (PANTOPRAZOLE) I.V., Wyeth Pharmaceuticals | Protonix I.V. (pantoprazole) Injection, Wyeth Pharma, Control Supplement | Protonix I.V. (pantoprazole sodium) Injection, Wyeth Pharma, Labeling Revision | Protonix (pantoprazole) Delayed-Release Tablets, Wyeth Pharma, Labeling Revision | Protonix I.V. (pantoprazole) Injection, Wyeth Pharma, New or Modified Indication | Protonix I.V. (pantoprazole sodium) Injection, Wyeth Pharma, Labeling Revision | Protonix I.V. (pantoprazole sodium) Injection, Wyeth Pharma, Control Supplement | Pantoprazole Sodium Delayed-Release Tablets, Teva Pharma, Tentative Approval | Pantoprazole Sodium Delayed-Release Tablets, Sandoz Inc., Tentative Approval | Pantoprazole Sodium Delayed-Release Tablets, Sun Pharma, Tentative Approval | Protonix (pantoprazole sodium) Delayed-Release Tablets, Wyeth Pharma, Labeling Revision
|